In our text, SALL4 was found lower expression in some kinds of glioma samples than non-tumor brain tissues, a certain extent like the SALL4-positive immunoreactivity was 58% in total 102 intrahepatic cholangiocarcinoma cases [45]. This evidence concerns the gene SALL4 and intrahepatic cholangiocarcinoma.